Webinar en español: IA y morfología hematológica | Dr. Pedro Martín-Cabrera
Una hora con el Dr. Pedro Martín-Cabrera, adjunto de Hematología y Hemoterapia en Cambridge University Hospitals NHS Foundation Trust (Reino Unido).
- All topics
- 1 assets
Webinar
February 07, 2024
Making science out of art: Digitization and Context in Full-Field Morphological Hematology
Traditionally, hematologists have relied on their keen eye and expertise to assess blood smears under…
Webinar
Workflow
October 18, 2023
A New Generation of Digital Morphology: How Fully Digital Remote Workflows Accelerate Diagnosis and Improve Patient Care
Complete blood counts requiring morphological examination are a notorious bottleneck in the hematology lab. They…
Webinar
May 13, 2023
Full-Field Digital Peripheral Blood and Bone Marrow Analysis: Innovation Meets Real-World Practice
Work volumes and staff shortages pose significant challenges to lab operations. Manual blood differentials (100-200…
Webinar
Full-Field Cell Morphology
November 15, 2022
The Rise of Full-Field Cell Morphology™ and the All-Digital Workflow
Full-Field Cell Morphology™ represents significant progress in standardization, efficiency, remote workflow capability, and scalability of hematological examination. It fundamentally changes laboratory practice and closes the gap between the manual and digital peripheral blood smear review.
Webinar
Thought leadership
October 18, 2022
A Digital Transformation in Hematopathology: The first Full-Field Bone Marrow Aspirate™ analysis platform
Bone marrow aspirate analysis is a complex and time consuming task, with significant variability in…
Webinar
Full-Field Cell Morphology
May 04, 2021
Dr. Ben-Zion Katz Presents the Multicenter Validation of Full-Field Digital Morphology for Peripheral Blood Smear Review
Dr. Ben-Zion Katz presents the multicenter study validating Full-Field digital morphology for peripheral blood smear review - including 60% faster workflow efficiency, 99.77% RBC morphology agreement, and high WBC and platelet accuracy across three clinical sites.